Reporting Alleged Ethics Violations Based on Publicly Available Documentation

Reporting Alleged Ethics Violations Based on Publicly Available Documentation

By the BACB

This video explores the Publicly Documented Alleged Violation reporting option. Please watch to learn about reporting requirements and considerations, the submission process, and more. Visit our Reporting Alleged Violations Based on Publicly Available Documentation web page for additional information.

You can find all of the BACB’s videos on our YouTube channel.

BACB Board of Directors Appointments

We are pleased to announce that the Board of Directors appointed Sadie Anderson as the next RBT Representative and Chrissy McNair as the next Consumer Representative on the Board of Directors. In August, they will begin their first three-year terms. The Board also appointed Molly Dubuque to serve a second term on the Board. We offer our congratulations to the appointed directors and our gratitude to all of the candidates who agreed to be considered for these positions.

COVID-19 Vaccine Considerations for BACB Certificants

March 21, 2022, Update: The following information was based on sections 1.01, 2.02, and 2.05 of the Professional and Ethical Compliance Code for Behavior Analysts and has since been updated to reflect the Ethics Code for Behavior Analysts.


The BACB commends all of its certificants who have endeavored to place the safety and needs of clients and staff at the forefront of their action plans to address the COVID-19 pandemic. The following information is being provided to our certificants as they make critical decisions about accessing COVID-19 vaccines.

The BACB offers the following considerations as certificants begin to move forward in the wake of newly available vaccines for COVID-19. This information does not constitute legal or medical advice, but it is consistent with the following standard from the Ethics Code for Behavior Analysts:

  • 3.01 Responsibility to Clients: “Behavior analysts act in the best interest of clients, taking appropriate steps to support clients’ rights, maximize benefits, and do no harm. They are also knowledgeable about and comply with applicable laws and regulations related to mandated reporting requirements.”

Certificants should also consider the recent guidance provided by the American Medical Association (AMA) Council on Ethical and Judicial Affairs for physicians from the November 2020 AMA Special Meeting. Specifically, the AMA (n.d.) states that:

  • “When … there is an available, safe, and effective vaccine, physicians have a responsibility to accept immunization absent a recognized medical contraindication or when a specific vaccine would pose a significant risk to the physician’s patients.”
  • “Physicians who are not or cannot be immunized have a responsibility to voluntarily take appropriate action to protect patients, fellow health care workers and others … including refraining from direct patient contact when appropriate.”
  • “Physician practices and health care institutions have a further responsibility to limit patient and staff exposure to individuals who are not immunized, which may include requiring unimmunized individuals to refrain from direct patient contact.”

The BACB urges certificants to consider the AMA’s guidance when making personal decisions and creating organization-level policies about accessing COVID-19 vaccines. Should the BACB receive a Notice of Alleged Violation related to this topic, the review committee would likely consider the following questions in determining whether a violation occurred:

  • Was there a vaccine available to reduce the negative impacts of the pandemic?
  • If the certificant could not be safely immunized or refused the vaccine for personal reasons, did they take and follow appropriate actions to protect clients, stakeholders, co-workers, supervisees, trainees, and others from potential exposure?
  • If the certificant was responsible for organization-level practices, did they take appropriate measures to protect clients, stakeholders, co-workers, supervisees, trainees, and others from exposure to nonimmunized individuals?

Reference

COVID-19 Vaccine Considerations for BACB Certificants

In the wake of newly available COVID-19 vaccines, certificants are faced with critical decisions that concern the safety and health of their clients, coworkers, and staff members, among others. To offer guidance on accessing COVID-19 vaccines as a behavior analyst, the BACB has compiled considerations from the American Medical Association and the Professional and Ethical Compliance Code for Behavior Analysts.

To learn more about these considerations, please visit our BACB COVID-19 Updates web page.

BACB Board of Directors Election Results

We are pleased to announce the results of our recent Board of Directors election: Eric Vici, BCaBA, and Julie Koudys, BCBA-D, were each elected to serve a three-year term on the board. We offer our congratulations to the elected directors and our gratitude to all of the candidates for running. We also extend our thanks to the certificants who participated in this important election.

RBT Remote Testing Restrictions Beginning March 1, 2021

When in-person testing was restricted due to the COVID-19 pandemic, the BACB sought approval from its accrediting body to participate in an exception program that offered flexibility for RBT candidates by permitting remote testing, with the understanding that additional data collection and security measures would be required. Remote testing became available for the RBT certification program on April 15, 2020.

On March 1, 2021, in response to typical examination-security concerns associated with remote testing, the BACB will begin restricting remote testing in select geographic regions as needed. If remote testing does not appear as an option at the time of examination-appointment scheduling, it is due to these restrictions, and in-person testing will still be available.

To learn more about the RBT remote testing restrictions, please visit our BACB COVID-19 Updates web page.

RBT Remote Testing Restrictions

When in-person testing was restricted due to the COVID-19 pandemic, the BACB sought approval from its accrediting body to participate in an exception program that offered flexibility for RBT candidates by permitting remote testing, with the understanding that additional data collection and security measures would be required. Remote testing became available for the RBT certification program on April 15, 2020.

On March 1, 2021, in response to typical examination-security concerns associated with remote testing, the BACB began restricting remote testing in select geographic regions as needed. If remote testing does not appear as an option at the time of examination-appointment scheduling, it is due to these restrictions, and in-person testing will still be available.

Frequently Asked Questions

Remote testing was approved in 2020 by the NCCA in response to the COVID-19 pandemic. Maintaining this examination-delivery method requires additional security measures, including restrictions when necessary, to meet the security requirements for the administration of high-stakes examinations.


The BACB continually monitors data from all of our examinations. When suspicious scores in any geographic region reach a particular threshold, we restrict access to remote testing in that region for an undetermined period of time to prevent lapses in examination security.


RBT candidates will be aware of the restriction at the time of scheduling their examination. If remote testing does not appear as an option at the time of examination-appointment scheduling, it is due to these restrictions, and in-person testing will still be available.


As an RBT Supervisor, you will need the help of the RBT candidates under your supervision to determine whether they are in a restricted area. Because restricted areas are updated regularly, the BACB is not able to provide additional information about geographic regions to supervisors or RBT candidates.

 

2021 Michael Hemingway Behavior Analysis Award

Dr. José Martinez-Diaz headshot

The BACB annually honors an individual to commemorate the life and contributions of Michael Hemingway, who played a central role in the development of behavior analyst certification in Florida before serving as a founding director of the BACB. Michael’s commitments to the profession of applied behavior analysis and to increasing access to services are reflected in the behavior of the individual who receives this award.

We are pleased to announce that the 2021 recipient of the Michael Hemingway Behavior Analysis Award is the late Dr. Jose Martinez-Diaz, BCBA-D (1950-2020). A former member of the BACB Board of Directors, Dr. Martinez-Diaz founded the behavior analysis training programs at Florida Institute of Technology. Through their on-campus and online offerings, Dr. Martinez-Diaz directly influenced thousands of students in their pursuit of education in behavior analysis. Through his professional accomplishments, he fully embodied the spirit and core purpose of applied behavior analysis: improve the lives of others. His teachings were based on a desire to better, strengthen, and grow the practice of behavior analysis to help protect vulnerable populations around the world, and he passed this personal mission on to his many students. In the kind words of his colleagues, peers, and students, he was a visionary, a fighter for justice, a beloved mentor, and a dear friend. We thank you and will miss you, Jose.